CIK 0001678660
- Non-accelerated filer
- Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811384762
- Phone
- +1 302-467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-07 | Mauro David J Chief Medical Officer | Sale | −1,400 | $30.35 | $42K | 13,600 |
| 2021-06-07 | Mauro David J Chief Medical Officer | Sale | −900 | $31.62 | $28K | 12,700 |
| 2021-06-07 | Mauro David J Chief Medical Officer | Sale | −12,700 | $32.73 | $416K | 0 |
| 2021-06-07 | Mauro David J Chief Medical Officer | Exercise or conversion · Common Stock | −15,000 | 197,610 | ||
| 2021-05-25 | Piper Brian Chief Financial Officer | Exercise or conversion | +8,333 | $1.89 | $16K | 8,333 |
| 2021-05-25 | Piper Brian Chief Financial Officer | Sale | −3,110 | $33.53 | $104K | 5,223 |
| 2021-05-25 | Piper Brian Chief Financial Officer | Sale | −3,088 | $34.11 | $105K | 2,135 |
| 2021-05-25 | Piper Brian Chief Financial Officer | Sale | −1,736 | $35.45 | $62K | 399 |
| 2021-05-25 | Piper Brian Chief Financial Officer | Sale | −399 | $36.09 | $14K | 0 |
| 2021-05-25 | Piper Brian Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −8,333 | 272,662 | ||
| 2021-05-07 | Scherle Peggy Chief Scientific Officer | Exercise or conversion | +10,000 | $1.43 | $14K | 182,920 |
| 2021-05-07 | Scherle Peggy Chief Scientific Officer | Sale | −3,964 | $40.30 | $160K | 178,956 |
| 2021-05-07 | Scherle Peggy Chief Scientific Officer | Sale | −5,836 | $41.14 | $240K | 173,120 |
| 2021-05-07 | Scherle Peggy Chief Scientific Officer | Sale | −200 | $41.85 | $8K | 172,920 |
| 2021-05-07 | Scherle Peggy Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −10,000 | 56,460 | ||
| 2021-05-05 | Mauro David J Chief Medical Officer | Exercise or conversion | +15,000 | $1.89 | $28K | 15,000 |
| 2021-05-05 | Mauro David J Chief Medical Officer | Sale | −3,415 | $39.36 | $134K | 11,585 |
| 2021-05-05 | Mauro David J Chief Medical Officer | Sale | −10,476 | $40.30 | $422K | 1,109 |
| 2021-05-05 | Mauro David J Chief Medical Officer | Sale | −1,109 | $41.07 | $46K | 0 |
| 2021-05-05 | Mauro David J Chief Medical Officer | Exercise or conversion · Common Stock | −15,000 | 212,610 |
Page 12 of 19 · 369 trades